Job Description

External stakeholders and decision makers are increasingly requesting demonstration of the comparative clinical, economic, and humanistic benefits of medicines at the time of launch, and ongoing through the asset lifecycle. GSK is developing several new medicines, all of which will require significant leadership and delivery from VEO to ensure successful payer coverage/health technology assessments (HTAs) and impactful value demonstration over the asset lifecycle.

To meet these needs, the Director, Value Evidence & Outcomes (VEO) - GCI, Specialty and GM is accountable for the development of robust and impactful real-world evidence generation strategies and the execution of tactical plans to support GCI value demonstration needs. It includes health outcomes leadership, execution for launch, and lifecycle management research programs. They will serve as the single point of accountability for the regional evidence generation planning and execution for assets within the Specialty and General Medicine TA portfolio; this includes both pipeline and marketed assets within the TA.

The Director, Value Evidence and Outcomes (VEO) - GCI, Specialty and GM reports to the GCI Head of VEO and will be managing a team. The person will plan, lead, and deliver innovative evidence solutions that incorporates external insights to ensure that asset strategies within their TAs provide the greatest common benefit across GCI, balancing the benefits of servicing priority and non-priority GCI markets. They will work closely with regional and local medical and access teams to understand GCI market policymakers, physician and payer needs. The Director will represent VEO on Global and Regional matrix teams and advise internal stakeholders in clinical development, medical affairs, market access, and commercial to support internal planning and decision-making during asset development and commercialization. They will manage budgets for GCI-focused studies and projects and will be responsible for governance related activities for study proposals. Additionally, the Director is expected to cultivate a rich external research network and represent GSK at a disease and asset-level at external professional, scientific meetings, and forums.

KEY RESPONSIBILITIES

Evidence Generation

Lead and/or provide oversight for the development, management, design, implementation and delivery of GCI evidence generation strategy and tactical plans for pipeline and marketed assets within the TA portfolio, including health technology assessment analyses, development of the value proposition for HTA bodies and the scientific community.

Maintain awareness of developments in the GCI health care environment and how these developments impact GCI evidence generation needs.

Provide input into Global VEO and integrated evidence plans/value evidence plans, to ensure GCI needs are accommodated.

Accountable for timely delivery of scientifically robust and impactful evidence for the assets within the TA.

Assigns asset responsibility to VEO Scientists within the TA in alignment with business priorities and resource availability.

Provides leadership, guidance and oversight in evidence strategy development and study methodology.

Ensures evidence generation activities are conducted with transparency, aligned to GSK processes and governance, are appropriately documented, are appropriately recorded within GSK systems and comply with necessary regulations for quality and disclosure.

Ensure VEO projects are delivered on time and on budget.

Evidence Communication

Develop scientific communications i.e., publication and dissemination plans, presentations, manuscripts, to communicate/disseminate evidence with external stakeholders.

Leverage health outcomes data with policymakers, payers and health care providers.

Train field staff on health outcomes data and promotional materials, as appropriate for organizational role.

Stakeholder Management

Build strong working relationships with Regional and Global stakeholders in Medical, Market Access, and Global VEO to ensure strategic alignment and optimal cross-functional collaboration and communication.

Develop and maintain excellent working relations with key stakeholders in the GCI LOCs to ensure capture of local insights and understanding of local needs.

GCI markets: Australia, China, Hong Kong, Japan, New Zealand, Singapore, South Korea and Taiwan.

Ensure key stakeholders including TA aligned business leaders are regularly updated on global and regional VEO plans through periodic reporting.

Develop excellent working relations with external thought leaders to ensure appropriate methods and research agendas are applied, in accordance with GSK policies.

Line Management

Leads, manages, and develops Therapy Area VEO Scientist(s) by:

Mentoring, coaching, and developing staff, ultimately to develop future health outcomes leaders.

Optimizing resources across TA portfolio priorities.

Driving best practice sharing across the team in support of strategy development and execution of tactical plans.

Removing barriers for execution of plans by enabling interactions with GCI LOC teams, cross-functional colleagues and other key partners.

Why you?

We are looking for professionals with the following required skills to achieve our goals:

Min a Master\xe2\x80\x99s degree in health economics, epidemiology or health outcomes

Min 8 years of experience in the pharmaceutical industry with min 5 years spent in a role within a pharmaceutical company

Min 8 years of experience in strategic planning and tactical application of evidence generation to support asset value demonstration

Understanding of Pharma R&D, especially clinical trial planning and execution.

Understanding of the GCI healthcare environment.

Experience with reimbursement and market access solutions for asset development and post-launch plans.

Experience with application of VEO research at the asset and therapy area levels.

Expertise in health economics, health outcomes, and comparative effectiveness research.

Experience with a variety of study designs, i.e., RWE studies including prospective, cross-sectional and retrospective cohort studies.

Ability to communicate technical and complex concepts and results effectively to a variety of audiences to impact decision making.

Leadership and management experience.

Excellent verbal, written, presentation and organizational skills.

Experienced in interacting with all levels of management and staff. Ability to work through complexity.

GSK is a global biopharma company with a special purpose \xe2\x80\x93 to unite science, technology and talent to get ahead of disease together \xe2\x80\x93 so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns \xe2\x80\x93 as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030. \xe2\x80\x8b

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it\xe2\x80\x99s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves \xe2\x80\x93 feeling welcome, valued and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.\xe2\x80\x8b

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK\'s commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

GlaxoSmithKline